@Fra, it is very old. Do not read anything into it.A startup funding report from the University of Michigan has just been released.
Auricle is briefly mentioned. Quote:
@Fra, it is very old. Do not read anything into it.A startup funding report from the University of Michigan has just been released.
Auricle is briefly mentioned. Quote:
It's not. It's linked from a UMich newsletter I just received on May 29th. The email stated the following:@Fra, it is very old. Do not read anything into it.
Accelerate Blue Fund Highlights $6.8M Total Investment in U-M Startups In 2024 Impact Report
The Accelerate Blue Fund recently published their 2024 Annual Report, detailing the Fund's performance and the progress of their portfolio companies. Pivotal in transforming research breakthroughs into tangible societal benefits, the Accelerate Blue Fund offers necessary seed capital to early-stage startups.
Isn't this just referring to the human trials they already completed?2024 Update: The AB Fund led a pre-seed round that enabled Auricle, Inc. to move forward with product development and human factors testing in preparation for obtaining FDA clearance.
Seeing Christopher in your profile picture reminds me of Phil Leotardo, who also wore a neck brace, and how poor posture has worsened the intensity of my tinnitus. A good reminder to focus on posture!UC Irvine is just a little bit farther from the University of Michigan.![]()
I would attend, but it appears Dr. Shore and I have swapped living locations...Is anyone planning to attend the seminar in person? It seems like a fantastic and rare opportunity to learn more about the current status of tinnitus research and the Shore Device.
Hello,
Unfortunately, this seminar will be in-person only, as it is a private event for the UCI community.
If Dr. Shore returns for another talk in the future and it is open via Zoom, we will be sure to share that information.
Best regards,
Thank you,
Department of Neurobiology and Behavior
Read the abstract. It is vague and uses the word "may." Nothing sounds promising.If anyone out there is local to UC Irvine and can get to the Dr. Susan Shore seminar tomorrow, that would be great! Unfortunately, no recording will be made available...![]()
This is not ideal, but academic language is much more restrained than advertising or everyday speech. Advertisers tend to exaggerate, and in casual conversation we often draw conclusions that would frustrate most academics.Read the abstract. It is vague and uses the word "may." Nothing sounds promising.
The last couple of trials showed clear efficacy, and her results have been reproduced at least once. This method definitely seems to work for somatosensory tinnitus.Read the abstract. It is vague and uses the word "may." Nothing sounds promising.
Now all Lenire needs is to introduce an after-sales follow-up, a heavy-duty persuasion session to convince the patient that their tinnitus has been cured. Like, no one can hear it... it is all in the mind.I have a theory on why Auricle is delayed.
I recently visited a new audiologist to establish care and discuss hearing aids for masking.
Two audiologists greeted me and introduced me to a representative from Lenire. The three of them then spent an hour delivering what felt like a scripted hard sell for Lenire. I am talking about sales tactics that resembled those used by timeshare salespeople. When I asked about hearing aids, their only response was, "Why don't you want to try the only FDA-approved device for tinnitus, Lenire?"
I have experienced less aggressive sales tactics when buying used cars. It became very clear that Lenire has a strong sales incentive program in place.
If Lenire has already partnered with many private practice audiologists in this way, then Auricle faces a serious sales and distribution challenge. They will need to displace Lenire in all of these existing relationships, which will be difficult given Lenire's first-mover advantage.
Auricle might obtain FDA approval but still struggle to establish a sales and distribution network because Lenire has already secured a strong foothold.
I forgot to mention this earlier, but the Lenire representative actually told me that the increase in my tinnitus after my acoustic trauma two years ago was psychosomatic, simply because I had very mild tinnitus before it. This, despite the fact that I could barely hear it in a quiet room back then and now I can hear it over a crashing waterfall. They were despicable.Now all Lenire needs is to introduce an after-sales follow-up, a heavy-duty persuasion session to convince the patient that their tinnitus has been cured. Like, no one can hear it... it is all in the mind.
Just kidding.
That said, I must confess that I benefited from TRT treatment back in the mid-1990s, although the ringing continued.
Sadly, my tinnitus has worsened. Maybe it is both age-related and noise-related, or perhaps it is due to my sensitive hearing.